null

DiMethyl-Histone H3-K4 Rabbit Polyclonal Antibody (CAB2356)

SKU:
CAB2356
Product Type:
Antibody
Applications:
WB
IHC
IF
IP
ChIP
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K4 Antibody CAB2356
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K4 Antibody CAB2356
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K4 Antibody CAB2356
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K4 Antibody CAB2356
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K4 Antibody CAB2356
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

DiMethyl-Histone H3-K4 Rabbit Polyclonal Antibody (CAB2356)

The Dimethyl-Histone H3 (K4) Polyclonal Antibody (CAB2356) is a valuable tool for researchers studying epigenetic modifications involved in gene regulation. This antibody, produced in rabbits, is highly specific to dimethylated histone H3 at lysine 4 (H3K4me2) and is validated for use in various applications, including immunofluorescence, immunoprecipitation, and chromatin immunoprecipitation (ChIP).Histone H3 methylation at lysine 4 is known to be associated with active gene transcription, making it a key epigenetic mark in the regulation of gene expression. The Dimethyl-Histone H3 (K4) Antibody enables researchers to specifically detect and study this modification in various cell types and tissues, providing valuable insights into the mechanisms underlying gene regulation and cellular functions.

By targeting dimethylated histone H3 at lysine 4, this antibody allows for the investigation of epigenetic changes that contribute to diseases such as cancer, neurodegenerative disorders, and developmental abnormalities. Understanding the role of H3K4me2 in these pathological conditions can lead to the development of novel therapeutic strategies targeting epigenetic pathways for disease treatment and prevention.